GLP-1 Receptor Gq vs Gi Coupling: What the 2026 Cryo-EM Structures Show

The glucagon-like peptide-1 receptor (GLP-1R) is usually described as a Gs-coupled receptor, but a 2026 structural study asked what happens when it meets other G proteins. This article, written for research use only, walks through what the new Gq and Gi cryo-EM structures show. It also covers what they leave open. It belongs alongside our overview of the incretin peptide class, and nothing here describes use in people or animals.

Why GLP-1R coupling beyond Gs is a structural question

In short: one receptor can talk to more than one G protein, and until recently nobody could see how.

G proteins are the molecular switches that sit just inside the cell membrane. When a receptor is activated by its peptide, it grabs a G protein and changes its shape, which sets off a signaling cascade. GLP-1R mainly couples to Gs, which raises the messenger molecule cAMP, but it also shows coupling to Gq/11 in signaling studies, according to the 2026 report in Acta Pharmaceutica Sinica B.

The authors frame the gap plainly: without structures of GLP-1R bound to Gq or Gi, there was no mechanistic explanation for effector selectivity or biased signaling. "Biased signaling" means a receptor favoring one downstream pathway over another. Seeing the contacts directly turns a signaling observation into a testable structural model.

The 2026 structures: Gq and Gi complexes

In short: two new maps, both with the natural peptide GLP-1 bound, at near-3 Å resolution.

Resolutions and database entries

The Gq complex was solved at 2.92 Å. Its map is deposited as EMD-66470 with the fitted model under PDB 9X22, and the associated publication is Zhou and colleagues, Acta Pharmaceutica Sinica B 2026, volume 16, pages 1779–1785. The map was deposited in October 2025 and released in March 2026. The Gi complex was solved at 3.18 Å and is available as PDB 9X20, released in May 2026.

For readers new to the method, resolution in angstroms (Å) describes how fine a detail the map resolves; smaller numbers are sharper. Values near 3 Å are usually good enough to place side chains with reasonable confidence, though it varies by region of the complex.

What was assembled

The Gi entry lists a Gαi1, Gβ1 and Gγ2 heterotrimer together with an scFv16 antibody fragment, a common tool for holding these complexes together on the grid. The ligand is GLP-1(7-36), a 30-residue peptide chain, and the structures are of the human receptor. Detailed construct and processing information sits in the paper's supporting material, which we have not reviewed here.

What stays the same: peptide pose and receptor core

In short: the receptor and its peptide look almost the same whichever G protein is attached.

According to the paper, GLP-1 binds in nearly identical modes in the Gq and Gi complexes. The differences are limited to side-chain orientations at the GLP-1 C-terminus and in extracellular loop 1 (ECL1). The transmembrane domain (TMD), the bundle of seven helices spanning the membrane, is also conserved when compared with the earlier Gs structure: the Cα root-mean-square deviation (RMSD) is 0.68 Å for Gq and 0.73 Å for Gi. The extracellular domain differs a little more, at 1.05 Å for Gq and 1.57 Å for Gi.

Why GLP-1R coupling beyond Gs is a structural question

In short: one receptor can talk to more than one G protein, and until recently nobody could see how.

The 2026 structures: Gq and Gi complexes

In short: two new maps, both with the natural peptide GLP-1 bound, at near-3 Å resolution.

Resolutions and database entries

What was assembled

What stays the same: peptide pose and receptor core

In short: the receptor and its peptide look almost the same whichever G protein is attached.

RMSD is just an average distance between matching atoms in two structures, so values below 1 Å mean the shapes nearly overlap. The takeaway: the receptor doesn't need to rebuild itself for each partner. For a related comparison of how two sibling receptors handle their peptides, see our piece on GLP-1R and GIPR compared by cryo-EM.

What changes: the G protein side

In short: most of the difference sits in how the G protein's helices meet the receptor, not in the receptor itself.

Shifts in the αN and α5 helices

The Gα subunit differs from the Gs-bound reference by 2.69 Å RMSD for Gq and 2.39 Å for Gi. The αN helix shows an inward shift in both: about 3.04 Å measured at the K10 to K17 Cα positions in Gαq and 2.97 Å in Gαi. The α5 helix, the part that plugs into the receptor, moves differently at its two ends. Its N-terminal region shifts downward (for example, N336 in Gαq against N371 in Gαs, a displacement of 4.13 Å) while the C-terminal tip stays nearly fixed.

The residue at that tip also differs between G proteins: F354 in Gαi, L394 in Gαs and V359 in Gαq. In the Gi complex this places the α5 tip farther from TM6, which the authors connect to weaker contact there.

Interface areas

The authors calculated buried interface areas with FreeSASA. In square angstroms:

Gs: 2045 total; 302.1 at the α5 tip; 417.2 for intracellular loop 2 (ICL2)
Gq: 1682 total; 358.9 at the α5 tip; 268.7 for ICL2
Gi: 1377 total; 219.3 at the α5 tip; 207.6 for ICL2

Gi has the smallest footprint, which the authors tie to its reduced α5–TM6 contact. For scale, they note that across class B1 GPCRs the mean Gs interface is 1925 Å², while Gq interfaces measure 1682 Å² for GLP-1R and 1392 Å² for PTH1R, and Gi interfaces measure 1282 Å² for GCGR and 1377 Å² for GLP-1R. A smaller interface doesn't by itself mean an unstable complex. Molecular dynamics simulations in the supplement suggest both Gαq and Gαi bind stably despite their smaller contact areas.

Mutagenesis: calcium versus cAMP readouts

In short: some receptor residues matter far more for Gq signaling than for Gs signaling.

To test the structures, the team mutated receptor residues and measured signaling in HEK293T cells, using calcium mobilization as the Gq readout and cAMP accumulation as the Gs readout. The pattern was clear. Several mutants lost calcium signaling entirely while keeping at least partial cAMP signaling:

R348A (TM6), which forms a polar network with α5 residues in Gαq, abolished Gq calcium signaling but only moderately affected Gs cAMP potency.
R176A (TM2), which forms salt bridges with E355 and E408 in the Gq complex, abolished calcium signaling and lowered cAMP potency 82-fold.
N338A (TM5) abolished calcium signaling and lowered cAMP potency about 3-fold.
L254A (ICL2), which contacts Y356 in Gαq but not the equivalent C351 in Gαi, abolished calcium signaling and only partly affected cAMP.
Three ECL3 mutants (D372N, E373Q, R380Q) abolished calcium signaling, with Gs signaling weakened but present.

Not every mutant favored Gs: K334A cut calcium Emax by 62% and also lowered cAMP potency 35-fold, and L201M abolished calcium signaling while lowering cAMP potency 109-fold. Gq coupling appeared more sensitive to specific contacts. That isn't the same as the two pathways being cleanly separable. These are cell-based assays, and a mutation can change expression or folding as well as a single contact.

Comparison with the 2017 Gs structure

In short: the Gs complex set the template, and the new structures show the same activated receptor with different partners.

The first GLP-1R–Gs structure, reported by Zhang and colleagues in Nature in 2017, reached 4.1 Å globally (3.9 Å in the core) using rabbit GLP-1R, which is 92% identical to the human receptor, together with a Gs heterotrimer and Nb35. Its signature feature was a sharp kink in the middle of TM6, at a Pro-X-X-Gly motif, that swings the intracellular half of the helix outward by roughly 18 Å (measured at Lys346) while TM5 moves about 7 Å. That opening creates the cavity into which the Gαs α5 helix docks.

The 2026 work does not describe a new TM6 opening. Instead, it points to small TM5/TM6 adjustments linked to ECL3 movement that may allow α5 insertion. The earlier structure used a different species and a lower resolution, so compare numbers across the two studies with care.

Limits and open questions

In short: this is a first look at two complexes, with GLP-1 only.

Only GLP-1 was used as the ligand. Biased peptides, other G protein subtypes and arrestin complexes are left by the authors for future work, and the principles proposed here need those structures to be tested. The interface areas are computed, the molecular dynamics results sit in the supplement, and the suggestion that the ECL3 network extends to other class B1 receptors and small-molecule agonists rests on supplementary data. If you are thinking about how ligand architecture might matter, our article on mono- versus dual-agonist structure covers a different angle; note that research-grade material is not equivalent to any FDA-approved pharmaceutical product of the same name.

Conclusion

The 2026 Gq and Gi structures show a GLP-1R transmembrane domain that holds a conserved active conformation, with GLP-1 bound almost identically, while the G protein's α5 and αN helices settle in different positions. Interface areas fall from Gs to Gq to Gi, and mutagenesis suggests Gq coupling leans harder on particular residues. The authors propose that selectivity comes mainly from α5 positioning, and that extracellular elements such as ECL3 may tune coupling allosterically. These are structural and cell-assay findings, and more ligands and partners will be needed to confirm how general they are.

Frequently Asked Questions

Does GLP-1R couple only to Gs?

No. Gs is the main partner and drives cAMP, but the receptor also shows coupling to Gq/11 in signaling studies. The 2026 structures give a molecular view of the Gq and Gi complexes.

Why is the Gi interface smaller than the Gs interface?

The calculated interface areas are 1377 square angstroms for Gi and 2045 for Gs. The authors link the smaller Gi footprint to reduced contact between the α5 helix and TM6, along with smaller ICL2 contact.

What do the mutagenesis experiments show?

Several receptor mutations abolished calcium signaling, the Gq readout, while only partly changing cAMP, the Gs readout. This suggests Gq coupling is more sensitive to specific contacts, though some mutants affected both pathways.

What are the limits of these structures?

Only GLP-1 was used as the ligand, the interface areas and simulations are computed rather than measured, and biased peptides and arrestin complexes were left to future work.

For research use only. Not for human or animal consumption of any kind. The information in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. The statements made have not been evaluated by the U.S. Food and Drug Administration. These products are NOT FDA APPROVED. Please consult with a licensed healthcare professional before making any decisions regarding your health or research.

Optides LLC is a chemical supplier. Optides LLC is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Optides LLC is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

Why GLP-1R coupling beyond Gs is a structural question

The 2026 structures: Gq and Gi complexes

Resolutions and database entries

What was assembled

What stays the same: peptide pose and receptor core

Why GLP-1R coupling beyond Gs is a structural question

The 2026 structures: Gq and Gi complexes

Resolutions and database entries

What was assembled

What stays the same: peptide pose and receptor core

What changes: the G protein side

Shifts in the αN and α5 helices

Interface areas

Mutagenesis: calcium versus cAMP readouts

Comparison with the 2017 Gs structure

Limits and open questions

Conclusion

Frequently Asked Questions

Does GLP-1R couple only to Gs?

Why is the Gi interface smaller than the Gs interface?

What do the mutagenesis experiments show?

What are the limits of these structures?

Stay Updated on New Research Compounds